Actively Recruiting
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
Led by ChinaNorm · Updated on 2025-06-15
76
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study plans to recruit 76 subjects in accordance with the above inclusion and exclusion criteria, with at least 60 subjects completing the study. The study period is 8 weeks, and the subjects need to visit the research center 4 times. After the subjects are enrolled, they will be randomly divided into two groups, including the experimental product group and the control product group. The physiological indicators of the skin were measured by objective instruments and compared with those of ordinary moisturizers without skin microecological regulation components to evaluate the repair promotion effect and improvement of La Roche-Posay's new B5 Multi-Effect Soothing and Repairing Cream on the affected areas of patients with mild atopic dermatitis on the
CONDITIONS
Official Title
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese males and females aged 18 to 65 years (inclusive)
- In good health without other chronic diseases or ongoing treatments
- Have received treatments for atopic dermatitis such as topical glucocorticoids, calcineurin inhibitors, oral antihistamines, or other topical medications
- Diagnosed with mild facial atopic dermatitis according to Yao's criteria and Investigator Global Assessment score of 2 or less
- At baseline, trans-epidermal water loss (TEWL) measurement value greater than 15g/m²/h
- Voluntarily agree to participate, understand, and sign informed consent
- Willing to use study products only, keep diaries, attend follow-ups, and follow study protocol throughout the study period
You will not qualify if you...
- Pregnant, planning pregnancy, breastfeeding, or within 6 months postpartum without contraception
- In acute exacerbation phase of atopic dermatitis
- Currently or recently (within 3 months) participating in other clinical trials
- Used functional moisturizers with skin microecology-regulating ingredients within 1 week before enrollment
- Received physical, chemical, or cosmetic surgical treatments within 3 months before enrollment
- Have systemic diseases with severe organ damage, malignancies, uncontrolled chronic diseases, acute infections, major surgeries or trauma, psychological disorders, or require treatments affecting atopic dermatitis
- Experience explosive worsening of atopic dermatitis lesions after treatments
- Have other skin diseases or conditions at the study site that interfere with evaluation
- Habitually scratch or squeeze atopic dermatitis lesions
- Known allergy to study products or ingredients
- Poor compliance or unwilling to follow study protocol
- Other reasons deemed inappropriate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, China, 200072
Actively Recruiting
Research Team
D
Danwei Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here